Tech Company M&A Transactions
Rempex Pharmaceuticals Acquisition
On 12/5/2013, Rempex Pharmaceuticals was acquired by The Medicines Company. The parties disclosed the acquisition price to be $474 million.
Transaction Overview
Company Name
Acquired By
Announced On
12/5/2013
Transaction Type
M&A
Amount
$474,000,000
M&A Terms
The Medicine Co. paid Rempex's stockholders $140 million up front and may pay potential milestone payments totaling $334 million.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
8 Sylvan Way
Parsippany, NJ 07054
USA
Parsippany, NJ 07054
USA
Phone
Website
Email Address
Overview
Rempex Pharmaceuticals, Inc. is a biopharmaceutical company whose mission is to develop important new therapies to combat the growing issue of antibiotic resistance.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Burgess
Chief Financial Officer
Eric Loumeau
Chief Medical Officer
Jeffery Loutit
Chief Operating Officer
Jennifer Cayer
Chief Scientific Officer
Michael Dudley
VP - Operations
Elizabeth Morgan
Browse more venture capital transactions:
Prev: 12/5/2013: Monetate venture capital transaction
Next: 12/5/2013: Sketchfab venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs